CompletedNot Applicable

Effectiveness of Nurse-coordinated Follow-up Program in Primary Care for People at Risk for T2DM

Iceland81 participantsStarted 2021-11-01

Plain-language summary

Previous Icelandic studies regarding prevalence of diabetes have mostly used data from the capital area. Information on the proportion of people at risk at developing T2DM or having undiagnosed T2DM among people living in rural Northern Iceland is unknown. Clinical guidelines recommend that patients with prediabetes (diabetes warning signs) should be referred to a counselling program. The study will evaluate effectiveness of nurse-coordinated Guided Self-Determination (GSD) follow up program toward health promotion, for people at risk of T2DM.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria two of three: * BMI ≥ 30 kg/m2, * score ≥ 9 on FINDRISC, * HbA1c level ≥ 42 mmol/mol. * Non-blood-glucose-lowering medical treated T2DM. Exclusion Criteria: * People diagnosed with Diabetes at strart-point.

What they're measuring

Cardiovascular Risk Factors changes up to one year after an intervention

Timeframe: 0- 6 months and 1 year

Measurements behind the Icelandic heart association risk calculator

Timeframe: 0- 6 months and 1 year

Trial details

NCT IDNCT04688359

SponsorUniversity of Akureyri

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-01-19

View on ClinicalTrials.gov More Pre-diabetes trials